| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cardiorenal risk reduction guidance in diabetes: can we reach consensus?
|
Sattar, Naveed
|
|
|
8 |
5 |
p. 357-360
|
article
|
| 2 |
Cardiovascular and heart failure outcomes with type 2 diabetes therapies: how important is weight loss?
|
Avogaro, Angelo
|
|
|
8 |
5 |
p. 353-355
|
article
|
| 3 |
β-cell secretory dysfunction: a key cause of type 2 diabetes
|
Holman, Rury R
|
|
|
8 |
5 |
p. 370
|
article
|
| 4 |
β-cell secretory dysfunction: a key cause of type 2 diabetes – Authors' reply
|
Weir, Gordon C
|
|
|
8 |
5 |
p. 370-371
|
article
|
| 5 |
Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Leere, Julius Simoni
|
|
|
8 |
5 |
p. 407-417
|
article
|
| 6 |
Diabetes in Scotland: a rising tide
|
Colhoun, Helen M
|
|
|
8 |
5 |
p. 375-376
|
article
|
| 7 |
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial
|
Yamada, Yuichiro
|
|
|
8 |
5 |
p. 377-391
|
article
|
| 8 |
DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database
|
Gouverneur, Amandine
|
|
|
8 |
5 |
p. 365-367
|
article
|
| 9 |
Francesco Rubino: formerly reluctant bariatric surgeon
|
Mitchell, Fiona
|
|
|
8 |
5 |
p. 372
|
article
|
| 10 |
Giving NCDs the attention they deserve
|
Morgan, Jules
|
|
|
8 |
5 |
p. 373
|
article
|
| 11 |
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials
|
Ghosh-Swaby, Olivia R
|
|
|
8 |
5 |
p. 418-435
|
article
|
| 12 |
Insulin access and affordability in the USA: anticipating the first interchangeable insulin product
|
Luo, Jing
|
|
|
8 |
5 |
p. 360-362
|
article
|
| 13 |
Knowledge gaps and weight stigma shape attitudes toward obesity
|
O'Keeffe, Majella
|
|
|
8 |
5 |
p. 363-365
|
article
|
| 14 |
Leopard skin
|
Henneicke, Holger
|
|
|
8 |
5 |
p. 456
|
article
|
| 15 |
Obesity-related stigma—hiding in plain sight
|
The Lancet Diabetes & Endocrinology,
|
|
|
8 |
5 |
p. 349
|
article
|
| 16 |
Oral semaglutide in Japanese versus non-Japanese patients with type 2 diabetes
|
Scheen, André J
|
|
|
8 |
5 |
p. 350-352
|
article
|
| 17 |
Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes
|
Ehrmann, Dominic
|
|
|
8 |
5 |
p. 436-446
|
article
|
| 18 |
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
|
Yabe, Daisuke
|
|
|
8 |
5 |
p. 392-406
|
article
|
| 19 |
Skeletal protection in patients with primary hyperparathyroidism
|
Minisola, Salvatore
|
|
|
8 |
5 |
p. 352-353
|
article
|
| 20 |
Stigma: undermining public health
|
Mitchell, Fiona
|
|
|
8 |
5 |
p. 374
|
article
|
| 21 |
The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement
|
Albury, Charlotte
|
|
|
8 |
5 |
p. 447-455
|
article
|
| 22 |
The NHS long-term plan: a comparison of the narrative used for cancer and obesity
|
Flint, Stuart W
|
|
|
8 |
5 |
p. 355-357
|
article
|
| 23 |
Type 1 diabetes—origins and epidemiology
|
Howard, Sarah G
|
|
|
8 |
5 |
p. 367-368
|
article
|
| 24 |
Type 1 diabetes—origins and epidemiology
|
Virtanen, Suvi M
|
|
|
8 |
5 |
p. 368-369
|
article
|
| 25 |
Type 1 diabetes—origins and epidemiology – Authors' reply
|
Norris, Jill M
|
|
|
8 |
5 |
p. 369-370
|
article
|
Journal description